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This study shows that the natural inhibitor protein of mitochondrial H+-ATPase complex (IFI) inhibits, 
in addition to the catalytic activity, the proton conductivity of the complex. The inhibition of ATPase activi- 
ty by IF, is less effective in the purified F1 than in submitochondrial particles where F, is bound to FO. No 
inhibition of H+ conductivity by F0 is observed in F,-depleted particles 
H+-ATPase; Inhibitor protein; Proton conductivity 
1. INTRODUCTION 
The natural ATPase inhibitor (IFI), originally 
isolated by Pullman and Monroy [l] from beef- 
heart mitochondria, is a small, heat-stable protein 
(i%& 10500). A similar protein was subsequently 
isolated from chloroplasts [2], bacteria [3], yeast 
[4,5] and liver [6,7]. The amino acid composition 
and sequence of IF1 from beef heart [B] and yeast 
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Abbreviations: Fo, membrane integral sector of the 
mitochondrial membrane; F1, catalytic part of 
mitochondrial H+-ATPase; IFI, natural inhibitor pro- 
tein of mitochondrial H+-ATPase; ESMP, sub- 
mitochondrial particles prepared in the presence of 
EDTA; Sephadex-ESMP, particles depleted of IFI by 
passing ESMP through a Sephadex column; USMP, par- 
ticles depleted of FI by urea treatment of 
Sephadex-ESMP 
[9] have been determined, showing a high degree of 
homology [IO]. This protein has been shown to af- 
fect the catalytic properties of the membrane- 
bound mitochondrial H+-ATPase complex 
(reviews [ 1 l-141) by binding to the P-subunit of F1 
[IS]. The catalytic activity of membrane-bound F1 
is compulsorily coupled to transmembrane proton 
translocation through the membrane sector of F. 
[16]. Removal [17] or displacement of Fl [18-221 
from its binding site(s) results in passive proton 
diffusion through the membrane sector in the 
absence of ATP hydrolysis or synthesis. In our 
laboratory a systematic study of the mechanism of 
proton conduction by the H+-ATPase complex has 
been carried out, following the anaerobic release 
of the transmembrane proton gradient generated 
by respiration in sonicated submitochondrial par- 
ticles with various degrees of resolution of the 
complex [18-221. From these studies it was shown 
that removal of IF1 from submitochondrial par- 
ticles results in enhancement of proton conduc- 
tance of the H+-ATPase complex [18,19]. 
Here, a kinetic analysis is presented of the role 
of IFI in the regulation of proton conductivity of 
the ATPase complex in sonicated submitochon- 
drial particles after resolution and reconstitution 
of the system. 
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2. MATERIALS AND METHODS 
Oligomycin and valinomycin were obtained 
from Sigma (St. Louis, MO); phosphoenofpyru- 
vate, pyruvate kinase, lactate dehydrogenase, ,& 
NAD reduced form, adenosine 5-triphosphate and 
catalase from Boehringer (Mannheim). All other 
chemicals were of high-purity grade. 
2.1. Preparation of submitochondrial particles 
ESMP were prepared as described by Lee and 
Ernster [23] by exposure of bovine heart mitochon- 
dria [24] to ultrasonic energy in the presence of 
EDTA at pH 8.5. The ATPase protein inhibitor 
was removed by passing ESMP through a 
Sephadex column (Sephadex-ESMP) [25]. USMP 
were prepared by urea treatment of Sephadex par- 
ticles as described in [ 181. 
2.2. Purtfication of FI and IFI 
Purification of Fr was performed by the 
chloroform extraction described by Beechey et al. 
[26]. This procedure is particularly convenient for 
being easy and rapid; however, it results in a lower 
activity of the ATPase as compared to other 
preparations [26]. IFi was prepared from Mg-ATP 
sonicated submitochondrial particles 1241 by the 
method of Kanner et al. (271 generally used for 
isolation of IF1 from purified ATPase complex 
[28-301. Polyacrylamide gel electrophoresis of the 
purified protein performed on slab gels of a linear 
polyacrylamide gradient (12-20%) as in [22] 
showed only one band of apparent M, 10500, 
ch~acteristic of IF1 preparations [ 1,6, lo] (fig. 1). 
2.3. Measurements of A TPase activity and H’ 
conductivity 
The ATPase activity was determined in the 
presence of added pyruvate kinase, phosphoeno~- 
pyruvate and lactate dehydrogenase by following 
NADH oxidation spectrophotometrically as in 
[221. 
For measurement of proton conduction the 
relaxation of the respiratory proton gradient was 
followed in sonicated particles (3 mg protein/ml) 
incubated in a reaction mixture containing 
250 mM sucrose, 30 mM KCI, 0.5 pg valinomy- 
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Fig.1. Gel electrophoresis of purified IFi. IFI (lOpg), 
purified as described in section 2, was added to 50~1 
aliquots of a solution containing 2.3% SDS, 5% 
2-mercaptoethanol, 10 mM Tris-HCI, pH 6.8, and 
exposed to ultrasonic energy for 60 s. Electrophoresis 
was then performed on slabs of a linear gradient 
polyacrylamide (12-20%) gel as in [22], The apparent 
A4, was determined by comparison with the following 
standard mixture of proteins: LKB 1860-101 M, markers 
containing: myoglobin (A4r 16949), myoglobin I and II 
(MI 14404); myoglobin I (iWr 8159); myoglobin II (Mr 
6214) and myoglobin III (MT 2512). 
cinlmg protein, 0.2 mglml purified catalase and 
20 mM succinate as respiratory substrate (final 
volume 1.5 ml, pH 7.5). Incubation was carried 
out in a glass vessel, under a constant stream of N2, 
at 25°C. Respiration-driven proton translocation 
was activated by repetitive pulses of i-390 Hz02 
(5 &‘ml). The pH changes monitored poten- 
tiometrically were converted into proton equi- 
valents by double titration with standard HCl and 
KOH [31]. H+ conductivity in the membrane was 
also measured by following potentiometrically the 
H+ release induced by a diffusion potential 
(positive inside) imposed by valinomycin-mediated 
K+ influx [32]. Protein concentration was deter- 
mined by the method of Lowry et al. [33]. 
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Table 1 
Resolution and reconstitution f H+-ATPase complex in 
sonicated submitochondrial particles: effect of IFI on 
ATPase activity 
ATPase activity 
(urn01 ATP hydrolyzed -
min-’ - mg protein-‘) 
Control + IFI % in- 
hibition 
ESMP 
Sephadex-ESMP 
USMP 
USMP + F, 
USMP + Fr + 
1.25 0.92 26 
2.18 0.98 55 
0.08 0.08 - 
1.00 0.50 50 
oligomycin (2 pg/mg 
protein) 0.12 - - 
Submitochondrial particles, Fi and IFI were prepared as 
described in section 2. Procedure: submitochondrial 
particles (5 mg/ml) were preincubated, when indicated, 
with IF,, at 4pg/mg particle protein, for 15 min at 
room temperature. Then 5Oyg particle protein were 
added to 1 ml of a mixture containing 250 mM sucrose, 
50 mM KCI, 20 mM Tris-HCl (pH 7.5), 0.025 mM 
NADH, 0.5 pg rotenone, 1 mM phosphoenolpyruvate, 
2.5 U lactate dehydrogenase, 2 U pyruvate kinase and 
ATPase activity was determined by following NADH 
oxidation at 340 nm. For reconstitution of oligomycin- 
sensitive ATPase activity, USMP (15 mg protein/ml) 
were incubated with 5 mM MgClz and 1.5 mg/ml FI (or 
1.5 mg/ml Fr + 50 pg/ml IFr) for 15 min, then SOpg 
particle protein were added to the reaction mixture and 
the ATPase activity determined as described above 
3. RESULTS 
Table 1 shows that removal of IFi from 
sonicated submitochondrial particles, effected by 
passing ESMP through a Sephadex column, 
resulted in an about 2-fold increase in ATPase ac- 
tivity. Addition of purified IFi, at 4 pg/mg particle 
protein, inhibited the ATPase activity of 
Sephadex-ESMP by 50%. 
The ATPase activity of USMP was negligible. 
Addition of soluble Fi to USMP resulted in 
oligomycin-sensitive ATPase activity which was in- 
hibited by IFI to the same extent as that observed 
in Sephadex-ESMP. Separate controls showed that 
the amount of IFi causing 50% inhibition of 
ATPase activity in Sephadex-ESMP and in the 
L--+--Ho e’o lb0 
IFI (pglmg F1) 
Fig.2. Titration curves for inhibition by IFI of the 
ATPase activity of purified FI. Fr and IFI were prepared 
as described in section 2. ATPase activity was 
determined as described in the legend to table 1 and the 
values shown are expressed as pmol ATP 
hydrolyzed. min- ’ - mg- ’ Fr protein. For preincubation 
of FI with IF,: Fr (5 mg/ml) were preincubated with IFi 
(at the concentrations shown) for 15 min at room 
temperature in the absence (M) or presence (m) 
of 5 mM MgClz. Then 5 cg protein of purified Fr were 
added to 1 ml reaction mixture for determination of the 
ATPase activity as described in the legend to table 1. 
reconstituted USMP plus Fi inhibited the ATPase 
activity in ESMP by only 26%. 
Titration of the inhibitory action of IFi on 
ATPase activity of soluble Fi is shown in fig.2. 
The inhibitory titre of the present preparation of 
IFi was similar to that exhibited by other prepara- 
tions on soluble FI [1,6], 50% inhibition being 
observed at around 50 pg IFi per mg protein solu- 
ble Fi (corresponding to about 2 mol added IF1 per 
mol Fi). The presence of Mg2+ during incubation 
of IFi with Fi caused some promotion of the in- 
hibitory effect of IFi. 
The results presented in table 2 and figs 3 and 4 
reveal that IFI also regulates the proton conduc- 
tivity of the H+-ATPase complex in sonicated sub- 
mitochondrial particles in the absence of ATP 
hydrolysis or synthesis. Removal of IFi (Sephadex- 
ESMP) resulted in a 2-3-fold enhancement of the 
rate of passive proton conduction measured as 
l/t%, either from the anaerobic relaxation of the 
respiratory proton gradient or from the H+ release 
69 
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Table 2 
Effect of IFi on passive proton conductivity in sonicated 
submito~hondrial particles 
Particles l/f, (s-l) 
Anaerobic H” release 
release of induced by 
respiratory valinomycin 
AfiH+ addition 
ESMP 
Sephadex-ESMP 
Sephadex-ESMP f IFi 
(4 pg/mg particle protein) 
1.00 0.50 
2.20 1.43 
1 .OO 0.50 
Particles and IF, were prepared as described in section 
2. H+ conductivity was measured potentiometrically as 
described in the text by following either anaerobic 
release of respiratory A,uH+ or I-I+ release induced by 
valinomycin addition in the presence of K”. Where 
indicated particles (20 mg particle protein/ml) were 
preincubated with IFI at the concentrations shown for 
15 min at room temperature, 0.23 ml of the mixture 
then being added to 1.27 ml reaction mixture 
3 6 9 
IF, Ipglmg psrtiele proteins) 
Fig.3. Titration curves for inhibition by IF1 of the Fig.4. Titration curve for inhibition of anaerobic release 
ATPase activity and passive proton conduction in of respiratory proton gradient by IFi in USMP after 
Sephadex-ESMP. Sephadex-ESMP and IFI were reconstitution of oligomycin-sensitive I-I+-ATPase by 
prepared as described in section 2. ATPase activity was addition of purified Fr. Preparations of USMP, Ft and 
determined as described in the legend to table 1 and the IFr were performed as described in section 2. For 
values shown are expressed as pm01 ATP hydrolyzed * reconstitution USMP (15 mglml) were incubated with 
min-’ - mg-’ particle protein. H+ conductivity was 0.1 mg Fr per mg particle protein and, where indicated, 
analyzed by following anaerobic release of the with the amounts of IF1 reported on the abscissa. After 
respiratory proton gradient as described in the legend to 15 min incubation 0.2 ml of the particle suspension were 
table 2. For preincubation of Sephadex-ESMP with IFi added to 0.8 ml reaction mixture, reported in the text, 
see legends to tables 1 and 2. (M) ATPase activity, and anaerobic release of respiratory proton gradient was 
(m) H+ conduction. measured potentiometri~~ly. 
induced by a K+ diffusion potential set up by 
valinomycin (table 2). Addition of 4pg IFi/mg 
particle protein to Sephadex-ESMP depressed the 
rate of passive proton conductivity to the values 
observed in ESMP. Separate controls showed that 
IFi had, on the other hand, no effect on proton 
conduction in Fi-depleted particles (USMP). 
Oligomycin caused about 80% inhibition of 
passive proton conduction in Sephadex-ESMP (as 
well as in ESMP and USMP) (see also 117-223). 
Fig.3 shows the titration curves for the in- 
hibitory action of IFi on ATPase activity and pro- 
ton conductivity of Sephadex-ESMP. The two 
curves practically coincide and are both biphasic, 
showing 50% inhibition for the two processes at 
about 4pg IFr/mg particle protein. 
As observed by others [6] about IO-fold less IF1 
was required per mg protein of particles to cause 
50% inhibition of the ATPase activity than with 
soluble FI. This could reflect the fact that FI 
represents only a fraction of the proteins of the in- 
ner mitochondrial membrane. 
Fig.4 shows that the Hf conduction in USMP, 
after reconstitution of oligomycin-sensitive 
H+-ATPase by addition to the particles of purified 
3 6 6" 
IF, (pglmg particle proteins) 
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Fr (see table l), was also inhibited by IFr, with a 
titration curve resembling that observed for 
Sephadex-ESMP. In this system the first phase of 
inhibition, observed at lower IF1 concentrations, 
was, however, more extensive than in Sephadex- 
ESMP. 50% inhibition was observed at a concen- 
tration of IF1 corresponding to 1 .O ,ug per mg pro- 
tein USMP and 10 pg per mg protein added Fr. 
4. DISCUSSION 
The present data show that IFi, besides control- 
ling the catalytic activities of mitochondrial 
H+-ATPase, plays a regulatory role in the proton 
conductivity by the FcFi complex in the absence of 
ATP hydrolysis or synthesis. Removal of IF1 from 
submitochondrial particles results in stimulation of 
oligomycin-sensitive hydrolytic activity (see also 
[l&19]) and of passive proton conductivity of the 
ATPase complex, which is reversed in both cases 
by adding back IFr. 
The inhibitory effect exerted by IFi on proton 
conductivity is not due to unspecific binding of the 
polypeptide to the membrane as shown by the 
specific requirement of Fr for this effect. In fact 
the inhibitory action exerted by IF1 on passive H+ 
conduction, lost in sonicated submitochondrial 
particles deprived of Fr (USMP), is recovered after 
reconstitution of the system by addition of soluble 
Fr to USMP. Thus the inhibitory action exerted by 
IFi on proton conduction depends on the presence 
of Fr. 
IFI could favour binding of Fi to FO with depres- 
sion of proton conductance. This may derive from 
a conformational change induced in Fr by the 
binding of IF1 to the&subunit [34,35]. It is, alter- 
natively, possible that IF1 mediates the binding of 
Fi to the membrane sector, thus acting as a compo- 
nent of the gate of the H+-ATPase complex. It 
can, in fact, be recalled in this respect that 
Hashimoto et al. [36-381 have isolated from yeast 
mitochondria two protein factors which stabilize 
the formation of an FoFr-IF1 complex, but do not 
exert any effect on the binding of IF1 to soluble Fr . 
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